Aequus Pharmaceuticals Inc (CVE:AQS) told investors that accomplished entrepreneur Grant Larsen had been hired as the company's chief commercial officer, effective August 17.
"The eye care medical market consisting of both prescription and OTC products is poised for double-digit growth, not only in Canada, but across North America," Larsen said in a statement.
READ: Aequus Pharmaceuticals completes C$2.5 million equity financing to launch its Evolve line of dry eye products
"My focus and the focus of our commercial team will be the launch of the Evolve line of eye drops and the continued growth in market share of our existing products."
Larsen has a strong background in strategic leadership, most recently as the past CEO of Eye Recommend, one of Canada’s largest cooperatives of optometrists. In addition, Larsen has also held senior positions at Allergan, Nikon Canada and Digital ECP.
He also has almost 20 years of senior management positions in North American eye care, said Aequus.
"We are delighted to have an accomplished entrepreneur and leader like Grant join our growing team,” said Aequus CEO Doug Janzen.
"As we prepare for the near-term launch of our Evolve line of eye care products we were looking for a Chief Commercial Officer with deep experience and relationships with Ophthalmologists, Optometrists and associated buyer groups and we are excited to welcome Grant to the team.”
Earlier this month, the group closed its previously announced public offering to raise around C$2.5 million in equity financing to raise funds to launch its Evolve preservative-free line of dry eye products.
Shares in Toronto added 3.57% to C$0.14 each.
---Updates for share price---
Contact the author at [email protected]